Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review

WY Fang, L Ravindar, KP Rakesh… - European Journal of …, 2019 - Elsevier
At present more than 250 FDA approved chlorine containing drugs were available in the
market and many pharmaceutically important drug candidates in pre-clinical trials. Thus, it is …

Indazole derivatives and their therapeutic applications: a patent review (2013-2017)

I Denya, SF Malan, J Joubert - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: Indazoles are heterocyclic moieties rarely found in nature. They are nitrogen
containing chemical compounds composed of a pyrazole ring condensed with a benzene …

Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders

B Kumar, AK Mantha, V Kumar - RSC advances, 2016 - pubs.rsc.org
Monoamine oxidase (MAO) enzyme catalyzes the oxidative deamination of xenobiotic and
endogenous amines including many neurotransmitters. The MAO enzyme exists in two …

Small-molecule inhibitors of reactive oxygen species production

E Sassetti, MH Clausen, L Laraia - Journal of Medicinal Chemistry, 2021 - ACS Publications
Reactive oxygen species (ROS) are involved in physiological cellular processes including
differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of …

Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: In vitro, in silico studies and ADME evaluation of monoamine oxidases and …

S Jalil, Z Hussain, SMA Abid, A Hameed, J Iqbal - RSC advances, 2024 - pubs.rsc.org
Alzheimer's disease (AD) is a multifactorial irreversible neurological disorder with multiple
enzymes involved. In the treatment of AD, multifunctional agents targeting cholinesterase …

Sensitive and selective ratiometric fluorescence probes for detection of intracellular endogenous monoamine oxidase A

X Wu, L Li, W Shi, Q Gong, X Li, H Ma - Analytical Chemistry, 2016 - ACS Publications
Monoamine oxidase A (MAO-A) is known to widely exist in most cell lines in the body, and its
dysfunction (unusually high or low levels of MAO-A) is thought to be responsible for several …

Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease

JS Lan, Y Ding, Y Liu, P Kang, JW Hou… - European journal of …, 2017 - Elsevier
Combining N-benzyl pyridinium moiety and coumarin into in a single molecule, novel
hybrids with ChE and MAO-B inhibitory activities were designed and synthesized. The …

Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease

SS **e, JS Lan, X Wang, ZM Wang, N Jiang, F Li… - Bioorganic & Medicinal …, 2016 - Elsevier
Combining N-benzylpiperidine moiety of donepezil and coumarin into in a single molecule,
novel hybrids with ChE and MAO-B inhibitory activity were designed and synthesized. The …

Pristine 2-chloroquinoline-based-thiosemicarbazones as multitarget agents against alzheimer's disease: In vitro and in silico studies of monoamine oxidase (MAO) …

S Jalil, R Basri, M Aziz, Z Shafiq, SA Ejaz… - Journal of Molecular …, 2024 - Elsevier
Neurodegenerative diseases can be treated more effectively with multitarget approaches.
monoamine oxidases (MAOs) acetylcholinesterase (AChE) and butyrylcholinesterase …

Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors

JW Choi, BK Jang, N Cho, JH Park, SK Yeon… - Bioorganic & Medicinal …, 2015 - Elsevier
We have synthesized three categories of α, β-unsaturated carbonyl derivatives and
evaluated their MAO-A and MAO-B inhibitory activities. Among them, compound 10b …